Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: A thrombolytic predictive instrument

Annals of Internal Medicine

Volumn 127, Issue 7, 1997, Pages 538-556

  Selker, Harry P ^a   Griffith, John L ^a   Beshansky, Joni R ^a   Schmid, Christopher H ^a   Califf, Robert M ^b   D'Agostino, Ralph B ^c   Laks, Michael M ^d   Lee, Kerry L ^b   Maynard, Charles ^e   Selvester, Ronald H ^e   Wagner, Galen S ^b   Weaver, W Douglas ^f  

^a TUFTS MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Boston University   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e Harbor UCLA Medical Center RB 2 ^*  (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; EMERGENCY MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

EID: 0030883718     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-7-199710010-00006     Document Type: Article

References (45)

1. Pozen MW, D'Agostino RB, Mitchell JB, Rosenfeld DM, Guglielmino JT, Schwartz ML, et al. The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med. 1980; 92(2 pt 1):238-42.
2. Pozen MW, D'Agostino RB, Selker HP, Sytkowski PA, Hood WB Jr. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med. 1984;310:1273-8.
3. Selker HP, D'Agostino RB, Laks MM. A predictive instrument for acute ischemic heart disease to improve coronary care unit admission practices: a potential on-line tool in a computerized electrocardiograph. J Electrocardiol. 1988;21(Suppl):S11-7.
4. Selker HP, Griffith JL, D'Agostino RB. A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study. Med Care. 1991;29:610-27.
5. Cairns CB, Niemann JT, Selker HP, Laks MM. Computerized version of the time-insensitive predictive instrument. Use of the Q wave, ST-segment, T wave, and patient history in the diagnosis of acute myocardial infarction by the computerized ECG. J Electrocardiol. 1991;24:46-9.
6. Sarasin FP, Reymond JM, Griffith JL, Beshansky JR, Schifferli JA, Unger PF, et al. Impact of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) on the speed of triage decision making for emergency department patients presenting with chest pain: a controlled clinical trial. J Gen Intern Med. 1994;9:187-94.
7. Selker HP, Beshansky JR, Griffith JL, for the TIPI Working Group. A controlled trial of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) electrocardiograph on emergency department (ED) triage [Abstract]. J Invest Med. 1995;43:215A.
8. Selker HP, Griffith JL. D'Agostino RB. A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study. Med Care. 1991;29:1196-211.
9. Selker HP, Griffith JL, D'Agostino RB. A time-insensitive predictive instrument for acute hospital mortality due to congestive heart failure: development, testing, and use for comparing hospitals: a multicenter study. Med Care. 1994;32:1040-52.
10. Selker HP. Systems for comparing actual and predicted mortality rates: characteristics to promote cooperation in improving hospital care [Editorial]. Ann Intern Med. 1993;118:820-2.
11. Selker HP, Griffith JL, Beshansky JR, Califf RM, D'Agostino RB, Laks MM, et al. The thrombolytic predictive instrument project: combining clinical study databases to take medical effectiveness research to the streets. Washington, DC: Agency for Health Care Policy Research: 1992:9-31.
12. Rosati RA, McNeer JF, Starmer CF, Mittler BS, Morris JJ Jr, Wallace AG. A new information system for medical practice. Arch Intern Med. 1975;135: 1017-24.
13. Pryor DP, Califf RM, Harrell FE Jr, Hlatky MA, Lee KL, Mark DB, et al. Clinical data bases. Accomplishments and unrealized potential. Med Care. 1985;23:623-47.
14. Weaver WD, Eisenberg MS, Martin JS, Litwin PE, Shaeffer SM, Ho MT, et al. Myocardial Infarction Triage and Intervention Project - phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990;15:925-31.
15. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317:581-8.
16. Topol EJ, Califf RM, George BS, Kereiakes DJ, Rothbaum D, Candela RJ, et al. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. Circulation. 1988;77:1100-7.
17. Topol EJ, George BS, Kereiakes DJ, Stump DC, Candela RJ, Abbottsmith CW, et al. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous hepann in acute myocardial infarction. Circulation. 1989;79:281-6.
18. Wall TC, Strickland J, Masoud J, Tse A, Pasi D, Zawodniak M, et al. Thrombolytic therapy on the homefront. Intravenous urokinase in community hospitals. N C Med J. 1989;50:363-6.
19. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of the thrombolysis and angioplasty in myocardial infarction - phase 5 randomized trial. TAMI Study Group. Circulation. 1991;83:1543-56.
20. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983;309:1477-82.
21. Kennedy JW, Martin GV, Davis KB, Maynard C, Stadius M, Sheehan FH, et al. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation. 1988;77:345-52.
22. Althouse R, Maynard C, Cerqueira MD, Olsufka M, Ritchie JL, Kennedy JW. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial. Am J Cardiol. 1990;66:1298-303.
23. Anderson WD, Wagner NB, Lee KL, White RD, Yuschak J, Behar VS, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts. Am J Cardiol. 1988;61:729-33.
24. Selker HP, Beshansky JR, Schmid CH, Griffith JL, Longstreth WT Jr, O'Connor CM, et al. Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument Project results. Circulation. 1994;90:1657-61.
25. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen T. The long QT syndrome: a prospective international study. Circulation. 1985;71:17-21.
26. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute, Inc.; 1989:1077-8.
27. Hastie TJ, Tibshirani RJ. Generalized Additive Models. London: Chapman & Hall; 1990:95-101.
28. Chambers JM, Hastie TJ. Statistical models in S. Pacific Grove, CA: Wadsworth and Brooks/Cole; 1992:249-377.
29. Centor RM. Signal detectability: the use of ROC curves and their analyses. Med Decis Making. 1991;11:102-6.
30. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-15.
31. Schmid CH, D'Agostino RB, Griffith JL, Beshansky JR, Selker HP. A logistic regression model when some events precede treatment: the effect of thrombolytic therapy for acute myocardial infarction on the risk of cardiac arrest. J Clin Epidemiol. 1997; [In press].
32. Hindman NB, Schocken DD, Widmann M, Anderson WD, White RD, Leggett S, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol. 1985;55:1485-90.
33. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343:311-22.
34. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
35. LaRosa JH, Horan MJ, Passamani ER, eds. Proceedings of the National Heart, Lung, and Blood Institute Symposium on Rapid Identification and Treatment of Acute Myocardial Infarction: Issues and Answers. Bethesda, MD: National Heart, Lung, and Blood Institute, U.S. Dept. of Health and Human Services, National Institutes of Health; 1992.
36. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270: 1211-6.
37. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1986;1:397-402
38. Marder VJ, Sherry S. Thrombolytic therapy: current status (2). N Engl J Med. 1988;318:1585-95.
39. Midgette AS. Griffith JL, Califf RM, Laks MM, Dietz SB, Beshansky JR, et al. Prediction of the infarct-related artery in acute myocardial infarction by a scoring system using summary ST-segment and T-wave changes. Am J Cardiol. 1996;78:389-95.
40. Gunnar RM, Bourdillon PD, Dixon DW, Fuster V, Karp RB, Kennedy JW, et al. ACC/AHA Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation. 1990;82:664-707.
41. Maynard C, Selker HP, Beshansky JR, Griffith JL, Schmid CH, Califf RM, et al. The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument database. Med Decis Making. 1995;15:38-43.
42. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med. 1992;117:916-21.
43. Selker HP. Coronary care unit triage decision aids: how do we know when they work? [Editorial] Am J Med. 1989;87:491-3.
44. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report. Ann Emerg Med. 1997; 29:1-12.
45. Selker HP, Zalenski RJ, Antman EM, Aufderheide TP, Bernard SA, Bonow RO, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med. 1997;29:13-87.